STING1 and breast cancer: LND-CDN that conjugates STING-activating cyclic dinucleotides (CDNs) to PEGylated lipids via a cleavable linker and incorporated them into lipid nanodiscs (LNDs), elicits tumor regression and facilitates robust T-cell activation in breast cancer and CRC (113).